AMICUS THERAPEUTICS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 45210
 
  
 
C07K PEPTIDES 14122
 
  
 
C07D HETEROCYCLIC COMPOUNDS 13149
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 13154
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 5120
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5201
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2136
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS147

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0319,710 METHODS FOR COUPLING TARGETING PEPTIDES ONTO RECOMBINANT LYSOSOMAL ENZYMES FOR IMPROVED TREATMENTS OF LYSOSOMAL STORAGE DISEASESNov 09, 16Nov 09, 17[A61K, C12N, C07K]
2017/0189,497 Augmented Acid Alpha-Glucosidase For The Treatment Of Pompe DiseaseDec 29, 16Jul 06, 17[A61K]
2016/0326,114 NOVEL COMPOSITIONS FOR PREVENTING AND/OR TREATING DEGENERATIVE DISORDERS OF THE CENTRAL NERVOUS SYSTEMJul 22, 16Nov 10, 16[A61K, C07D]
2015/0086,530 DOSING REGIMENS FOR THE TREATMENT OF POMPE DISEASEMay 02, 13Mar 26, 15[A61K]
2010/0119,502 THERAPY REGIMENS, DOSING REGIMENS AND STABLE MEDICAMENTS FOR THE TREATMENT OF POMPE DISEASENov 11, 09May 13, 10[A61K, A61P]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9889203 Chemical crosslinkersMar 14, 14Feb 13, 18[A61K, C12N, C07K]
9867862 Compounds and method for treating or preventing disease conditions associated with alpha-1-antitrypsinFeb 23, 15Jan 16, 18[A61K, C12Q, C07C, C07K]
9827189 Stable parenteral DNJ compositionsJan 09, 14Nov 28, 17[A61K]
9821038 Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activityFeb 13, 17Nov 21, 17[A61K, C12N, C07K]
9750733 Compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous systemOct 10, 16Sep 05, 17[A61K, C07D]
9694056 α-galactosidase A and 1-deoxygalactonojirimycin co-formulationJul 16, 13Jul 04, 17[A61K, C12N]
9675627 Dosing regimens for treating and/or preventing cerebral amyloidosesApr 13, 15Jun 13, 17[A61K]
9597324 Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymesOct 03, 14Mar 21, 17[A61K, C12Q, G01N]
9598438 Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of MPS IIICFeb 12, 15Mar 21, 17[A61K, C07D]
9566316 Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activityJan 04, 16Feb 14, 17[A61K, C12N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0219,986 DOSING REGIMENS FOR THE TREATMENT OF FABRY DISEASEAbandonedMar 08, 12Aug 07, 14[A61K]
2013/0102,538 METHOD OF TREATING ALZHEIMER'S DISEASE USING PHARMACOLOGICAL CHAPERONES TO INCREASE PRESENILIN FUNCTION AND GAMMA-SECRETASE ACTIVITYAbandonedMay 04, 11Apr 25, 13[A61K]
8399525 Treatment of gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markersExpiredApr 11, 08Mar 19, 13[A61K, C12Q]
2012/0283,290 QUANTITATION OF GL3 IN URINEAbandonedMay 04, 12Nov 08, 12[H01J, C07H, A61K, C12Q]
2012/0083,010 METHOD FOR DIAGNOSING POMPE DISEASEAbandonedAug 18, 11Apr 05, 12[C12Q]
2011/0268,721 Therapy Regimens, Dosing Regimens And Stable Medicaments For The Treatment Of Pompe DiseaseAbandonedMay 11, 11Nov 03, 11[A61K, A61P]
2011/0189,710 TREATMENT OF POMPE DISEASE WITH SPECIFIC PHARMACOLOGICAL CHAPERONES AND MONITORING TREATMENT USING SURROGATE MARkERSAbandonedMar 12, 09Aug 04, 11[C12Q]
2011/0152,319 METHOD TO PREDICT RESPONSE TO PHARMACOLOGICAL CHAPERONE TREATMENT OF DISEASESAbandonedAug 20, 10Jun 23, 11[A61K, C12Q, A61P]
2011/0136,151 ASSAYS FOR DIAGNOSING AND EVALUATING TREATMENT OPTIONS FOR POMPE DISEASEAbandonedMar 12, 09Jun 09, 11[G01N]
2011/0104,727 ASSAYS FOR DIAGNOSING AND EVALUATING TREATMENT OPTIONS FOR FABRY DISEASEAbandonedDec 13, 10May 05, 11[C12Q]
2011/0070,643 Utilization of Pharmacological Chaperones to Improve Manufacturing and Purification of BiologicsAbandonedMay 26, 10Mar 24, 11[C12N]
2010/0197,018 USE OF SUBSTRATES AS PHARMACOLOGICAL CHAPERONESAbandonedApr 11, 08Aug 05, 10[C12N]
2010/0189,708 HYDROXY PIPERIDINE DERIVATIVES TO TREAT GAUCHER DISEASEAbandonedApr 08, 10Jul 29, 10[A61K, A61P]
2010/0113,517 METHOD FOR THE TREATMENT OF FABRY DISEASE USING PHARMACOLOGICAL CHAPERONESAbandonedMar 28, 08May 06, 10[A61K, A61P]
2007/0021,433 Pharmacological chaperones for treating obesityAbandonedJun 02, 06Jan 25, 07[A61K]
2006/0293,250 Crystalline sugar compositions and method of makingAbandonedJun 08, 06Dec 28, 06[A61K, C07H]
2006/0293,508 Stabilization of triflated compoundsAbandonedJun 08, 06Dec 28, 06[C07H]
2005/0137,223 Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher diseaseAbandonedNov 12, 04Jun 23, 05[A61K, C07D]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.